- Latest available (Revised)
- Point in Time (16/04/2015)
- Original (As adopted by EU)
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Version Superseded: 10/08/2016
Point in time view as at 16/04/2015.
There are currently no known outstanding effects for the Regulation (EC) No 1223/2009 of the European Parliament and of the Council, ANNEX IV.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Without prejudice to other provisions in this Regulation, a colorant shall include its salts and lakes and when a colorant is expressed as a specific salt, its other salts and lakes shall also be included.
a For use as a UV-Filter, see Annex VI, No. 27. | |||||||||
Reference number | Substance identification | Conditions | Wording of conditions of use and warnings | ||||||
---|---|---|---|---|---|---|---|---|---|
Chemical Name | Colour index Number/Name of Common Ingredients Glossary | CAS number | EC number | Colour | Product type, Body parts | Maximum concentration in ready for use preparation | Other | ||
a | b | c | d | e | f | g | h | i | j |
1 | Sodium tris(1,2-naphthoquinone 1-oximato-O,O')ferrate(1-) | 10006 | Green | Rinse-off products | |||||
2 | Trisodium tris[5,6-dihydro-5-(hydroxyimino)-6-oxonaphthalene-2-sulphonato(2-)-N5,O6]ferrate(3-) | 10020 | Green | Not to be used in products applied on mucous membranes | |||||
3 | Disodium 5,7-dinitro-8-oxidonaphthalene-2-sulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 10316 | Yellow | Not to be used in eye products | |||||
4 | 2-[(4-Methyl-2-nitrophenyl)azo]-3-oxo-N-phenylbutyramide | 11680 | Yellow | Not to be used in products applied on mucous membranes | |||||
5 | 2-[(4-Chloro-2-nitrophenyl)azo]-N-(2-chlorophenyl)-3-oxobutyramide | 11710 | Yellow | Not to be used in products applied on mucous membranes | |||||
6 | 2-[(4-Methoxy-2-nitrophenyl)azo]-3-oxo-N-(o-tolyl)butyramide | 11725 | Orange | Rinse-off products | |||||
7 | 4-(Phenylazo)resorcinol | 11920 | Orange | ||||||
8 | 4-[(4-Ethoxyphenyl)azo]naphthol | 12010 | Red | Not to be used in products applied on mucous membranes | |||||
9 | 1-[(2-Chloro-4-nitrophenyl)azo]-2-naphthol and its insoluble barium, strontium and zirconium lakes, salts and pigments | 12085 | Red | 3 % | |||||
10 | 1-[(4-Methyl-2-nitrophenyl)azo]-2-naphthol | 12120 | Red | Rinse-off products | |||||
11 | 3-Hydroxy-N-(o-tolyl)-4-[(2,4,5-trichlorophenyl)azo]naphthalene-2-carboxamide | 12370 | Red | Rinse-off products | |||||
12 | N-(4-Chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide | 12420 | Red | Rinse-off products | |||||
13 | 4-[(2,5-Dichlorophenyl)azo]-N-(2,5-dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide | 12480 | Brown | Rinse-off products | |||||
14 | N-(5-Chloro-2,4-dimethoxyphenyl)-4-[[5-[(diethylamino)sulphonyl]-2-methoxyphenyl]azo]-3-hydroxynaphthalene-2-carboxamide | 12490 | Red | ||||||
15 | 2,4-Dihydro-5-methyl-2-phenyl-4-(phenylazo)-3H-pyrazol-3-one | 12700 | Yellow | Rinse-off products | |||||
16 | Disodium 2-amino-5-[(4-sulphonatophenyl)azo]benzenesulphonate | 13015 | Yellow | ||||||
17 | Sodium 4-(2,4-dihydroxyphenylazo)benzenesulphonate | 14270 | Orange | ||||||
18 | Disodium 3-[(2,4-dimethyl-5-sulphonatophenyl)azo]-4-hydroxynaphthalene-1-sulphonate | 14700 | Red | ||||||
19 | Disodium 4-hydroxy-3-[(4-sulphonatonaphthyl)azo]naphthalenesulphonate | 14720 | 222-657-4 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 122) | ||||
20 | Disodium 6-[(2,4-dimethyl-6-sulphonatophenyl)azo]-5-hydroxynaphthalene-1-sulphonate | 14815 | Red | ||||||
21 | Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 15510 | Orange | Not to be used in eye products | |||||
22 | Calcium disodium bis[2-chloro-5-[(2-hydroxy-1-naphthyl)azo]-4-sulphonatobenzoate] | 15525 | Red | ||||||
23 | Barium bis[4-[(2-hydroxy-1-naphthyl)azo]-2-methylbenzenesul-phonate] | 15580 | Red | ||||||
24 | Sodium 4-[(2-Hydroxy-1-naphthyl)azo]naphthalenesulphonate | 15620 | Red | Rinse-off products | |||||
25 | Sodium 2-[(2-hydroxynaphthyl)azo]naphthalenesulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 15630 | Red | 3 % | |||||
26 | Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate] | 15800 | Red | Not to be used in products applied on mucous membranes | |||||
27 | Disodium 3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azo]-2-naphthoate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 15850 | 226-109-5 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 180) | ||||
28 | Disodium 4-[(5-chloro-4-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 15865 | Red | ||||||
29 | Calcium 3-hydroxy-4-[(1-sulphonato-2-naphthyl)azo]-2-naphthoate | 15880 | Red | ||||||
30 | Disodium 6-hydroxy-5-[(3-sulphonatophenyl)azo]naphthalene-2-sulphonate | 15980 | Orange | ||||||
31 | Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 15985 | 220-491-7 | Yellow | Purity criteria as set out in Commission Directive 95/45/EC (E 110) | ||||
32 | Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate | 16035 | 247-368-0 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 129) | ||||
33 | Trisodium 3-hydroxy-4-[(4'-sulphonatonaphthyl)azo]naphthalene-2,7-disulphonate | 16185 | 213-022-2 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 123) | ||||
34 | Disodium 7-hydroxy-8-(phenylazo)naphthalene-1,3-disulphonate | 16230 | Orange | Not to be used in products applied on mucous membranes | |||||
35 | Trisodium 1-(1-naphthylazo)-2-hydroxynaphthalene-4',6,8-trisulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 16255 | 220-036-2 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 124) | ||||
36 | Tetrasodium 7-hydroxy-8-[(4-sulphonato-1-naphthyl)azo]naphthalene-1,3,6-trisulphonate | 16290 | Red | ||||||
37 | Disodium 5-amino-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 17200 | Red | ||||||
38 | Disodium 5-acetylamino-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonate | 18050 | 223-098-9 | Red | Not to be used in products applied on mucous membranes | Purity criteria as set out in Commission Directive 95/45/EC (E 128) | |||
39 | 2,7-Naphthalenedisulfonic acid, 3-((4-cyclohexyl-2-methylphenyl)azo)-4-hydroxy-5-(((4-methylphenyl)sulfonyl)amino)-, disodium salt | 18130 | Red | Rinse-off products | |||||
40 | Hydrogen bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-) | 18690 | Yellow | Rinse-off products | |||||
41 | Disodium hydrogen bis[5-chloro-3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxybenzenesulphonato(3-)]chromate(3-) | 18736 | Red | Rinse-off products | |||||
42 | Sodium 4-(3-hydroxy-5-methyl-4-(phenylazo)pyrazol-2-yl)benzenesulphonate | 18820 | Yellow | Rinse-off products | |||||
43 | Disodium 2,5-dichloro-4-(5-hydroxy-3-methyl-4-((sulphophenyl)azo)pyrazol-1-yl)benzenesulphonate | 18965 | Yellow | ||||||
44 | Trisodium 5-hydroxy-1-(4-sulphophenyl)-4-((4-sulphophenyl)azo)pyrazole-3-carboxylate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 19140 | 217-699-5 | Yellow | Purity criteria as set out in Commission Directive 95/45/EC (E 102) | ||||
45 | N,N'-(3,3'-Dimethyl[1,1'-biphenyl]-4,4'-diyl)bis[2-[(2,4-dichlorophenyl)azo]-3-oxobutyramide] | 20040 | Yellow | Rinse-off products | Maximum 3,3'-dimethylbenzidine concentration in the colouring agent: 5 ppm | ||||
46 | Sodium 4-amino-5-hydroxy-3-((4-nitrophenyl)azo)-6-(phenylazo)naphthalene-2,7-disulphonate | 20470 | Black | Rinse-off products | |||||
47 | 2,2'-[(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-3-oxobutyramide] | 21100 | Yellow | Rinse-off products | Maximum 3,3'-dimethylbenzidine concentration in the colouring agent: 5 ppm | ||||
48 | 2,2'-[(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutyramide] | 21108 | Yellow | Rinse-off products | Maximum 3,3'-dimethylbenzidine concentration in the colouring agent: 5 ppm | ||||
49 | 2,2'-[Cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis[4-cyclohexylphenol] | 21230 | Yellow | Not to be used in products applied on mucous membranes | |||||
50 | Disodium 4,6-dihydroxy-3-[[4-[1-[4-[[1-hydroxy-7-[(phenylsulphonyl)oxy]-3-sulphonato-2-naphthyl]azo]phenyl]cyclohexyl]phenyl]azo]naphthalene-2-sulphonate | 24790 | Red | Rinse-off products | |||||
51 | 1-(4-(Phenylazo)phenylazo)-2-naphthol | 26100 | Red | Not to be used in products applied on mucous membranes | Purity criteria: aniline ≤ 0,2 % 2-naphtol ≤ 0,2 % 4-aminoazobenzene ≤ 0,1 % 1-(phenylazo)-2-naphtol ≤ 3 % 1-[2-(phenylazo)phenylazo]-2-napthalenol ≤ 2 % | ||||
52 | Tetrasodium 6-amino-4-hydroxy-3-[[7-sulphonato-4-[(4-sulphonatophenyl)azo]-1-naphthyl]azo]naphthalene-2,7-disulphonate | 27755 | Black | ||||||
53 | Tetrasodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate | 28440 | 219-746-5 | Black | Purity criteria as set out in Commission Directive 95/45/EC (E 151) | ||||
54 | Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, disodium salt, reaction products with 4-[(4-aminophenyl)azo] benzenesulfonic acid, sodium salts | 40215 | Orange | Rinse-off products | |||||
55 | beta Carotene | 40800 | 230-636-6 | Orange | Purity criteria as set out in Commission Directive 95/45/EC (E160a) | ||||
56 | 8'-apo-.beta.-Caroten-8'-al | 40820 | Orange | Purity criteria as set out in Commission Directive 95/45/EC (E 160e) | |||||
57 | Ethyl 8'-apo-.beta.-caroten-8'-oate | 40825 | 214-173-7 | Orange | Purity criteria as set out in Commission Directive 95/45/EC (E 160f) | ||||
58 | Canthaxanthin | 40850 | 208-187-2 | Orange | Purity criteria as set out in Commission Directive 95/45/EC (E 161g) | ||||
59 | Ammonium, (4-(alpha-(p-(diethylamino)phenyl)-2,4-disulfobenzylidene)-2,5-cyclohexadien-1-ylidene)diethyl-, hydroxide, monosodium salt | 42045 | Blue | Not to be used in products applied on mucous membranes | |||||
60 | Ethanaminium, N-(4-((4-(diethylamino)phenyl)(5-hydroxy-2,4-disulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, hydroxide, inner salt, calcium salt (2:1) and its insoluble barium, strontium and zirconium lakes, salts and pigments | 42051 | 222-573-8 | Blue | Purity criteria as set out in Commission Directive 95/45/EC (E 131) | ||||
61 | Benzene-methanaminium, N-ethyl-N-(4-((4-(ethyl((3-sulfophenyl)methyl)amino) phenyl)(4-hydroxy-2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt | 42053 | Green | ||||||
62 | Hydrogen (benzyl)[4-[[4-[benzylethylamino]phenyl](2,4-disulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)ammonium, sodium salt | 42080 | Blue | Rinse-off products | |||||
63 | Benzene-methanaminium, N-ethyl-N-(4-((4-(ethyl((3-sulfophenyl)methyl)amino) phenyl)(2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt | 42090 | 223-339-8 | Blue | Purity criteria as set out in Commission Directive 95/45/EC (E 133) | ||||
64 | Hydrogen [4-[(2-chlorophenyl)[4-[ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt | 42100 | Green | Rinse-off products | |||||
65 | Hydrogen [4-[(2-chlorophenyl)[4-[ethyl(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt | 42170 | Green | Rinse-off products | |||||
66 | (4-(4-Aminophenyl)(4-iminocyclohexa-2,5-dienylidene)methyl)-2-methylaniline hydrochloride | 42510 | Violet | Not to be used in products applied on mucous membranes | |||||
67 | 4-[(4-Amino-m-tolyl)(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]-o-toluidine monohydrochloride | 42520 | Violet | Rinse-off products | 5ppm | ||||
68 | Hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt | 42735 | Blue | Not to be used in products applied on mucous membranes | |||||
69 | [4-[[4-Anilino-1-naphthyl][4-(dimethylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride | 44045 | Blue | Not to be used in products applied on mucous membranes | |||||
70 | Hydrogen [4-[4-(dimethylamino)-.alpha.-(2-hydroxy-3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, monosodium salt | 44090 | 221-409-2 | Green | Purity criteria as set out in Commission Directive 95/45/EC (E 142) | ||||
71 | Hydrogen 3,6-bis(diethylamino)-9-(2,4-disulphonatophenyl)xanthylium, sodium salt | 45100 | Red | Rinse-off products | |||||
72 | Hydrogen 9-(2-carboxylatophenyl)-3-(2-methylanilino)-6-(2-methyl-4-sulphoanilino)xanthylium, monosodium salt | 45190 | Violet | Rinse-off products | |||||
73 | Hydrogen 9-(2,4-disulphonatophenyl)-3,6-bis(ethylamino)-2,7-dimethylxanthylium, monosodium salt | 45220 | Red | Rinse-off products | |||||
74 | Disodium 2-(3-oxo-6-oxidoxanthen-9-yl)benzoate | 45350 | Yellow | 6 % | |||||
75 | 4',5'-Dibromo-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one and its insoluble barium, strontium and zirconium lakes, salts and pigments | 45370 | Orange | Not more than 1 % 2-(6-hydroxy-3-oxo-3H-xanthen-9-y1) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid | |||||
76 | Disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 45380 | Red | Not more than 1 % 2-(6-hydroxy-3-oxo-3H-xanthen-9-y1) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid | |||||
77 | 3',6'-Dihydroxy-4',5'-dinitrospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one | 45396 | Orange | 1 %, when used in lip products | Only in free acid form, when used in lip products | ||||
78 | Dipotassium 3,6-dichloro-2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate | 45405 | Red | Not to be used in eye products | Not more than 1 % 2-(6-hydroxy-3-oxo-3Η xanthen-9-yl) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid | ||||
79 | 3,4,5,6-Tetrachloro-2-(1,4,5,8-tetrabromo-6-hydroxy-3-oxoxanthen-9-yl)benzoic acid and its insoluble barium, strontium and zirconium lakes, salts and pigments | 45410 | Red | Not more than 1 % 2-(6-hydroxy-3-oxo-3Η xanthen-9-yl) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid | |||||
80 | Disodium 2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirconium lakes, salts and pigments | 45430 | 240-474-8 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 127) | ||||
81 | 1,3-Isobenzofurandione, reaction products with methylquinoline and quinoline | 47000 | Yellow | Not to be used in products applied on mucous membranes | |||||
82 | 1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts | 47005 | 305-897-5 | Yellow | Purity criteria as set out in Commission Directive 95/45/EC (E 104) | ||||
83 | Hydrogen 9-[(3-methoxyphenyl)amino]-7-phenyl-5-(phenylamino)-4,10-disulphonatobenzo[a]phenazinium, sodium salt | 50325 | Violet | Rinse-off products | |||||
84 | Sulfonated nigrosine color | 50420 | Black | Not to be used in products applied on mucous membranes | |||||
85 | 8,18-Dichloro-5,15-diethyl-5,15-dihydrodiindolo[3,2-b:3',2'-m]triphenodioxazine | 51319 | Violet | Rinse-off products | |||||
86 | 1,2-Dihydroxyanthraquinone | 58000 | Red | ||||||
87 | Trisodium 8-hydroxypyrene-1,3,6-trisulphonate | 59040 | Green | Not to be used in products applied on mucous membranes | |||||
88 | 1-Anilino-4-hydroxyanthraquinone | 60724 | Violet | Rinse-off products | |||||
89 | 1-Hydroxy-4-(p-toluidino)anthraquinone | 60725 | Violet | ||||||
90 | Sodium 4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluene-3-sulphonate | 60730 | Violet | Not to be used in products applied on mucous membranes | |||||
91 | 1,4-bis(p-Tolylamino)anthraquinone | 61565 | Green | ||||||
92 | Disodium 2,2'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(5-methylsulphonate) | 61570 | Green | ||||||
93 | Sodium 3,3'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(2,4,6-trimethylbenzenesulphonate) | 61585 | Blue | Rinse-off products | |||||
94 | Sodium 1-amino-4-(cyclohexylamino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate | 62045 | Blue | Rinse-off products | |||||
95 | 6,15-Dihydroanthrazine-5,9,14,18-tetrone | 69800 | Blue | ||||||
96 | 7,16-dichloro-6,15-dihydroanthrazine-5,9,14,18-tetrone | 69825 | Blue | ||||||
97 | Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione | 71105 | Orange | Not to be used in products applied on mucous membranes | |||||
98 | 2-(1,3-Dihydro-3-oxo-2H-indazol-2-ylidene)-1,2-dihydro-3H-indol-3-one | 73000 | Blue | ||||||
99 | Disodium 5,5'-(2-(1,3-dihydro-3-oxo-2H-indazol-2-ylidene)-1,2-dihydro-3H-indol-3-one)disulphonate | 73015 | 212-728-8 | Blue | Purity criteria as set out in Commission Directive 95/45/EC (E 132) | ||||
100 | 6-Chloro-2-(6-chloro-4-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4-methylbenzo[b]thiophene-3(2H)-one | 73360 | Red | ||||||
101 | 5-Chloro-2-(5-chloro-7-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-7-methylbenzo[b]thiophene-3(2H)-one | 73385 | Violet | ||||||
102 | 5,12-Dihydroquino[2,3-b]acridine-7,14-dione | 73900 | Violet | Rinse-off products | |||||
103 | 5,12-Dihydro-2,9-dimethylquino[2,3-b]acridine-7,14-dione | 73915 | Red | Rinse-off products | |||||
104 | 29H,31H-Phthalocyanine | 74100 | Blue | Rinse-off products | |||||
105 | 29H,31H-Phthalocyaninato(2-)-N29,N30,N31,N32 copper | 74160 | Blue | ||||||
106 | Disodium [29H,31H-phthalocyaninedisulphonato (4-)-N29,N30,N31,N32] cuprate (2-) | 74180 | Blue | Rinse-off products | |||||
107 | Polychloro copper phthalocyanine | 74260 | Green | Not to be used in eye products | |||||
108 | 8,8'-diapo-.psi.,.psi.-Carotenedioic acid | 75100 | Yellow | ||||||
109 | Annatto | 75120 | 215-735-4/289-561-2/230-248-7 | Orange | Purity criteria as set out in Commission Directive 95/45/EC (E 160b) | ||||
110 | Lycopene | 75125 | — | Yellow | Purity criteria as set out in Commission Directive 95/45/EC (E 160d) | ||||
111 | CI Food Orange 5 | 75130 | 214-171-6 | Orange | Purity criteria as set out in Commission Directive 95/45/EC (E 160a) | ||||
112 | (3R)-beta-4-Caroten-3-ol | 75135 | Yellow | ||||||
113 | 2-Amino-1,7-dihydro-6H-purin-6-one | 75170 | White | ||||||
114 | Curcumins | 75300 | 207-280-5 | Yellow | Purity criteria as set out in Commission Directive 95/45/EC (E 100) | ||||
115 | Carmines | 75470 | 215-680-6/215-023-3/215-724-4 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 120) | ||||
116 | Trisodium (2S-trans)-[18-carboxy-20-(carboxymethyl)-13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21H,23H-porphine-2-propionato(5-)-N21,N22,N23,N24]cuprate(3-) (Chlorophylls) | 75810 | 215-800-7/207-536-6/208-272-4/287-483-3/239-830-5/246-020-5 | Green | Purity criteria as set out in Commission Directive 95/45/EC (E 140, E 141) | ||||
117 | Aluminium | 77000 | 231-072-3 | White | Purity criteria as set out in Commission Directive 95/45/EC (E 173) | ||||
118 | Aluminium hydroxide sulphate | 77002 | White | ||||||
119 | Natural hydrated aluminium silicate, Al2O3.2SiO2.2H2O, containing calcium, magnesium or iron carbonates, ferric hydroxide, quartz-sand, mica, etc. as impurities | 77004 | White | ||||||
120 | Lazurite | 77007 | Blue | ||||||
121 | Aluminum silicate coloured with ferric oxide | 77015 | Red | ||||||
122 | Barium sulfate | 77120 | White | ||||||
123 | Bismuth chloride oxide | 77163 | White | ||||||
124 | Calcium carbonate | 77220 | 207-439-9/215-279-6 | White | Purity criteria as set out in Commission Directive 95/45/EC (E 170) | ||||
125 | Calcium sulfate | 77231 | White | ||||||
126 | Carbon black | 77266 | 215-609-9 | Black | Purity criteria as set out in Commission Directive 95/45/EC (E 153) | ||||
127 | Charcoal, bone. A fine black powder obtained by burning animal bones in a closed container. It consists primarily of calcium phosphate and carbon | 77267 | Black | ||||||
128 | Coke black | 77268:1 | Black | ||||||
129 | Chromium (III) oxide | 77288 | Green | free from chromate ion | |||||
130 | Chromium (III) hydroxide | 77289 | Green | free from chromate ion | |||||
131 | Cobalt Aluminum Oxide | 77346 | Green | ||||||
132 | Copper | 77400 | Brown | ||||||
133 | Gold | 77480 | 231-165-9 | Brown | Purity criteria as set out in Commission Directive 95/45/EC (E 175) | ||||
134 | Iron oxide | 77489 | Orange | ||||||
135 | Iron Oxide Red | 77491 | 215-168-2 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 172) | ||||
136 | Iron Oxide Yellow | 77492 | 51274-00-1 | 257-098-5 | Yellow | Purity criteria as set out in Commission Directive 95/45/EC (E 172) | |||
137 | Iron Oxide Black | 77499 | 235-442-5 | Black | Purity criteria as set out in Commission Directive 95/45/EC (E 172) | ||||
138 | Ferric Ammonium Ferrocyanide | 77510 | Blue | free from cyanide ions | |||||
139 | Magnesium carbonate | 77713 | White | ||||||
140 | Ammonium manganese(3+) diphosphate | 77742 | Violet | ||||||
141 | Trimanganese bis (orthophosphate) | 77745 | Red | ||||||
142 | Silver | 77820 | 231-131-3 | White | Purity criteria as set out in Commission Directive 95/45/EC (E 174) | ||||
143 | Titanium dioxidea | 77891 | 236-675-5 | White | Purity criteria as set out in Commission Directive 95/45/EC (E 171) | ||||
144 | Zinc oxide | 77947 | White | ||||||
145 | Riboflavin | Lactoflavin | 201-507-1/204-988-6 | Yellow | Purity criteria as set out in Commission Directive 95/45/EC (E 101) | ||||
146 | Caramel | Caramel | 232-435-9 | Brown | Purity criteria as set out in Commission Directive 95/45/EC (E 150a-d) | ||||
147 | Paprika extract, Capsanthin, capsorubin | Capsanthin, capsorubin | 207-364-1/207-425-2 | Orange | Purity criteria as set out in Commission Directive 95/45/EC (E 160c) | ||||
148 | Beetroot red | Beetroot Red | 7659-95-2 | 231-628-5 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 162) | |||
149 | Anthocyanins (Cyanidin, Peonidin Malvidin Delphinidin Petunidin Pelargonidin) | Anthocyanins | 528-58-5 134-01-0 528-53-0 643-84-5 134-04-3 | 208-438-6 205-125-6 211-403-8 208-437-0 — 205-127-7 | Red | Purity criteria as set out in Commission Directive 95/45/EC (E 163) | |||
150 | Aluminium, zinc, magnesium and calcium stearates | Aluminum stearate Zinc stearate Magnesium stearate Calcium stearate | 7047-84-9 557-05-1 557-04-0 216-472-8 | 230-325-5 209-151-9 209-150-3 216-472-8 | White | ||||
151 | Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-, S,S-dioxide | Bromothymol blue | 76-59-5 | 200-971-2 | Blue | Rinse-off products | |||
152 | Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-3-methyl-,S,S-dioxide | Bromocresol green | 76-60-8 | 200-972-8 | Green | Rinse-off products | |||
153 | Sodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonate | Acid red 195 | 12220-24-5 | — | Red | Not to be used in products applied on mucous membranes |
The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: